T1	Treatment 10 32	alpha 1-blocker, YM617
T2	Treatment 136 256	alpha 1-blocker, (R)(-)-5-[2-[[2-(o-ethoxyphenoxy)ethyl]amino]propyl]-2- methoxybenzenesulfonamide hydrochloride (YM617)
T3	Treatment 364 371	placebo
T4	Treatment 428 438	P--placebo
T5	Treatment 499 505	YM617.
T6	Treatment 520 527	placebo
T7	Treatment 1565 1588	alpha 1-blocker, YM617.
